Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Addiction Medicine
Mixed hepatitis C genotypes in injection drug users cut antiviral efficacy
June 17th, 2005
Mixed hepatitis C genotypes in injection drug users cut antiviral efficacy. "Multiple genotypes of the hepatitis C virus (HCV) were detected in 5 of 138 HCV RNA positive injecting drug users (IDUs) recruited in Melbourne, Australia," investigators in Australia report. "Two were detected by combined LiPA and core and NS5a region sequencing, and three more (selected for testing due to their high- risk behavior) by heteroduplex mobility analysis," according to S. Bowden and colleagues, Macfarlane Burnet Institute for Medical Research and Public Health, Epidemiology and Social Research Program. "We conclude that the true prevalence of...
Source: Drug Week (2005-06-17)
|
